The invention relates to compounds of the formula I ##STR1##

in which R1, R2, R3, R4 and X have the meaning indicated in the text. The compounds act as inhibitors of factors Xa and VIIa and can therefore be employed for the control and prevention of thromboembolic conditions such as thrombosis, myocardial infarct, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty and intermittent claudication.

 
Web www.patentalert.com

< Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors

< Endothelin antagonists

> Method for identifying or characterizing properties of polymeric units

> Thrombotic episode risk assays using oxidized phospholipids

~ 00208